Jonathan Hellmann1, Robin Knighton2, Shoo K Lee3, Prakesh S Shah3. 1. Division of Neonatology, Hospital for Sick Children, Toronto, Canada Department of Paediatrics, University of Toronto, Toronto, Canada Department of Bioethics, Hospital for Sick Children, Toronto, Canada. 2. Division of Neonatology, Hospital for Sick Children, Toronto, Canada. 3. Department of Paediatrics, University of Toronto, Toronto, Canada Department of Paediatrics, Mount Sinai Hospital, Toronto, Canada.
Abstract
OBJECTIVE: To determine the causes and process of death in neonates in Canada. DESIGN: Prospective observational study. SETTING: Nineteen tertiary level neonatal units in Canada. PARTICIPANTS: 942 neonatal deaths (215 full-term and 727 preterm). EXPOSURE AND OUTCOME: Explored the causes and process of death using data on: (1) the rates of withdrawal of life-sustaining treatment (WLST); (2) the reasons for raising the issue of WLST; (3) the extent of consensus with parents; (4) the consensual decision-making process both with parents and the multidisciplinary team; (5) the elements of WLST; and (6) the age at death and time between WLST and actual death. RESULTS: The main reasons for deaths in preterm infants were extreme immaturity, intraventricular haemorrhage and pulmonary causes; in full-term infants asphyxia, chromosomal anomalies and syndromic malformations. In 84% of deaths there was discussion regarding WLST. WLST was agreed to by parents with relative ease in the majority of cases. Physicians mainly offered WLST for the purpose of avoiding pain and suffering in imminent death or survival with a predicted poor quality of life. Consensus with multidisciplinary team members was relatively easily obtained. There was marked variation between centres in offering WLST for severe neurological injury in preterm (10%-86%) and severe hypoxic-ischaemic encephalopathy in full-term infants (5%-100%). CONCLUSIONS AND RELEVANCE: In Canada, the majority of physicians offered WLST to avoid pain and suffering or survival with a poor quality of life. Variation between units in offering WLST for similar diagnoses requires further exploration. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVE: To determine the causes and process of death in neonates in Canada. DESIGN: Prospective observational study. SETTING: Nineteen tertiary level neonatal units in Canada. PARTICIPANTS: 942 neonatal deaths (215 full-term and 727 preterm). EXPOSURE AND OUTCOME: Explored the causes and process of death using data on: (1) the rates of withdrawal of life-sustaining treatment (WLST); (2) the reasons for raising the issue of WLST; (3) the extent of consensus with parents; (4) the consensual decision-making process both with parents and the multidisciplinary team; (5) the elements of WLST; and (6) the age at death and time between WLST and actual death. RESULTS: The main reasons for deaths in preterm infants were extreme immaturity, intraventricular haemorrhage and pulmonary causes; in full-term infantsasphyxia, chromosomal anomalies and syndromic malformations. In 84% of deaths there was discussion regarding WLST. WLST was agreed to by parents with relative ease in the majority of cases. Physicians mainly offered WLST for the purpose of avoiding pain and suffering in imminent death or survival with a predicted poor quality of life. Consensus with multidisciplinary team members was relatively easily obtained. There was marked variation between centres in offering WLST for severe neurological injury in preterm (10%-86%) and severe hypoxic-ischaemic encephalopathy in full-term infants (5%-100%). CONCLUSIONS AND RELEVANCE: In Canada, the majority of physicians offered WLST to avoid pain and suffering or survival with a poor quality of life. Variation between units in offering WLST for similar diagnoses requires further exploration. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
Ethics; Mortality; Neonatology; Palliative Care
Authors: J W Sheehan; M Pritchard; R J Heyne; L S Brown; M A Jaleel; W D Engle; P J Burchfield; L P Brion Journal: J Perinatol Date: 2016-12-15 Impact factor: 2.521
Authors: Jennifer James; David Munson; Sara B DeMauro; John C Langer; April R Dworetz; Girija Natarajan; Margarita Bidegain; Christine A Fortney; Ruth Seabrook; Betty R Vohr; Jon E Tyson; Edward F Bell; Brenda B Poindexter; Seetha Shankaran; Rosemary D Higgins; Abhik Das; Barbara J Stoll; Haresh Kirpalani Journal: J Pediatr Date: 2017-06-21 Impact factor: 4.406
Authors: April R Dworetz; Girija Natarajan; John Langer; Kathy Kinlaw; Jennifer R James; Margarita Bidegain; Abhik Das; Brenda Poindexter; Edward F Bell; C M Cotten; Haresh Kirpalani; Seetha Shankaran; Barbara J Stoll Journal: Arch Dis Child Fetal Neonatal Ed Date: 2020-10-20 Impact factor: 5.747
Authors: Karin Zimmermann; Eva Bergstraesser; Sandra Engberg; Anne-Sylvie Ramelet; Katrin Marfurt-Russenberger; Nicolas Von der Weid; Chantal Grandjean; Patricia Fahrni-Nater; Eva Cignacco Journal: BMC Palliat Care Date: 2016-03-09 Impact factor: 3.234